ECM
XENT

ExodusPoint Capital Management’s Intersect ENT, Inc XENT Stock Holding History

ExodusPoint Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-44,700
Closed -$1.01M – 2782
2020
Q4 		$1.01M Buy
+44,700
New +$851K 0.01% 856

ExodusPoint Capital Management's XENT Position: Q2 2022 in Review

ExodusPoint Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 43,152 shares — an estimated $1.21M sold.

ExodusPoint Capital Management first reported a position in XENT in Q2 2020 and held it in 5 quarters. The position peaked at $3.26M in Q4 2020. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • ExodusPoint Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 43,152 Intersect ENT, Inc shares in Q2 2022, an estimated $1.21M.
  • ExodusPoint Capital Management first reported a position in Intersect ENT, Inc in Q2 2020 and held it in 5 quarters.
  • ExodusPoint Capital Management's Intersect ENT, Inc position peaked at $3.26M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.